Clinical Trials Browser

Biliary Tract Neoplasms × Trastuzumab × 90 days × Clear all

NCT06178445 2026-03-27

TRAP-BTC

Phase 2 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma